StockWatch
·
Pharmaceuticals
Subsidiary9 Jul 2026, 08:40 pm

Anlon Healthcare Incorporates Subsidiary ANLON MEDICARE PRIVATE LIMITED

AI Summary

Anlon Healthcare Limited has announced the incorporation of its wholly-owned subsidiary, ANLON MEDICARE PRIVATE LIMITED, effective July 09, 2026. This new entity, with a CIN U21006GJ2026PTC180329, will focus on manufacturing surgical implants and medical devices. The incorporation is part of Anlon Healthcare's strategy to complement and expand its existing business in the pain management segment, leveraging significant growth opportunities in the sector. The subsidiary has an authorized share capital of ₹5,000,000 and a paid-up share capital of ₹2,000,000. Anlon Healthcare Limited has subscribed to equity shares worth ₹1,100,000, holding 55% of the subsidiary's share capital.

Key Highlights

  • Anlon Healthcare incorporated a new subsidiary, ANLON MEDICARE PRIVATE LIMITED.
  • The subsidiary will manufacture surgical implants and medical devices.
  • This move aims to expand Anlon Healthcare's presence in the pain management segment.
  • Initial investment in the subsidiary is ₹1,100,000 for a 55% stake.
  • The subsidiary is incorporated with an authorized capital of ₹5,000,000.